Results 111 to 120 of about 607,655 (152)

Temporal Trends in Janus Kinase Inhibitor (JAKi) Use Across Five European Countries: A DARWIN EU Network Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Introduction Janus kinase inhibitors (JAKi) are increasingly used for autoimmune conditions despite existing safety concerns. This study aims to estimate the incidence of new JAKi use over time and characterise users in Europe to support future safety studies.
Xihang Chen, Andrei Barbulescu, George Corby, Saeed Hayati, Annika Jodicke, Toni Lehtonen, Hedvig Marie Egeland Nordeng, Alexandra Pacurariu, Gabriel Sanfélix‐Gimeno, Nhung T. H. Trinh, Katia Verhamme, Dina Vojinovic, Daniel Prieto‐Alhambra, Amy Shuk‐Man Lam, Edward Burn   +14 more
wiley   +1 more source

Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis

Reumatismo
Objective. The aim of the current study was to compare the clinical and treatment characteristics and dimensions of health-related quality of life between female and male patients with axial spondyloarthritis (SpA) and psoriatic arthritis (PsA ...
B. Ristic, C. Bonetto, M. Rossini, E. Fracassi, A. Carletto, S. Tosato   +5 more
doaj   +1 more source

Superior Clinical and Economic Value of IL‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis

International Journal of Dermatology, Volume 65, Issue 11, Page 2362-2370, November 2026.
A bicentric retrospective real‐world study (N = 616) comparing IL‐23 inhibitors (guselkumab, risankizumab, tildrakizumab) with adalimumab biosimilars in moderate‐to‐severe plaque psoriasis. It presents PASI90 response at Weeks 16 and 52, NNT, and cost‐effectiveness (incremental cost per responder, CE plane, CEAC/CEAF).
Gennaro Marco Falco, Elena Ippoliti, Niccolò Gori, Giacomo Caldarola, Clara De Simone, Nicoletta Di Giorgi, Paulo Gabriel Longo, Marco Galluzzo, Luca Bianchi, Lorenzo Marcelli, Marina Talamonti, Maria Vittoria Cannizzaro, Lucia Di Nardo, Ketty Peris   +13 more
wiley   +1 more source

Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic review

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 11, Page 1796-1807, November 2026.
This systematic review evaluated prognostic prediction models used to assess the risk of future psoriatic arthritis in psoriasis patients. The included studies reported modest to moderate performance measures, with limited external validation, inadequate reporting and high risk of bias.
Fatimah Khoda, Yasmin Khan, William W. Y. Haw, Sayeda Nahar, Claire Hodkinson, Hector Chinoy, Richard B. Warren, Glen P. Martin, Zenas Z. N. Yiu   +8 more
wiley   +1 more source

Developments in psoriasis and psoriatic arthritis

, 2008
Psoriasis and psoriatic arthritis are common conditions for which treatment options have until recently been extremely limited. Recent advances in our understanding of the immunology and genetics underlying these conditions have been rapid, and have ...
Marie Feletar, Brown, Matthew A., Feletar, M., Foley, P., Peter Foley, Foley, Peter, Matthew A. Brown, Feletar, Marie   +7 more
core   +1 more source

Formal and Informal Social Care in People With Rheumatic and Musculoskeletal Diseases: A Cross‐Sectional Multicenter Survey

Arthritis Care &Research, Volume 78, Issue 10, Page 1522-1531, October 2026.
Objective Rheumatic and musculoskeletal diseases (RMDs) are leading causes of physical disability, necessitating support with activities of daily living. This study describes social care received by patients with RMDs in two disparate regions of England: Salford (urban) and Norfolk (rural).
Mehreen Somro, Karen Durrant, William G. Dixon, John McBeth, Alex MacGregor, Max Yates, Jenny H. Humphreys   +6 more
wiley   +1 more source

Functional Impact of Structural Damage in Psoriatic Arthritis: Insights from a Prospective Cohort Study

Arthritis &Rheumatology, Volume 78, Issue 10, Page 2102-2109, October 2026.
Objective To examine the association between radiographic structural damage and physical function (PF) in psoriatic arthritis (PsA). Methods Data were analyzed from a large longitudinal PsA cohort. PF was measured using the Health Assessment Questionnaire (HAQ, 0–3) and Short Form‐36 PF subscale (SF‐36, 0–100); radiographic joint damage was measured ...
Pankti Mehta, Shangyi Gao, Virginia Carrizo Abarza, Fadi Kharouf, Daniel Pereira, Richard J. Cook, Dafna D. Gladman, Vinod Chandran, Denis Poddubnyy   +8 more
wiley   +1 more source

Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data

Arthritis &Rheumatology, Volume 78, Issue 10, Page 2160-2170, October 2026.
Objective Immune checkpoint inhibitors (ICIs) for cancer can lead to immune‐related adverse events, including ICI‐associated inflammatory arthritis (ICI‐IA). There are no validated International Classification of Diseases (ICD) code–based case definitions for ICI‐IA.
Manar Elsayed, Zoe Hsu, Finlay A. McAlister, William D. Leslie, Lisa M. Lix, Sasha Bernatsky, Suzanne N. Morin, Michelle M. Graham, Aurore Fifi‐Mah, Shahin Jamal, Janet Roberts, Carrie Ye   +11 more
wiley   +1 more source

Epidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 7, October 2026.
ABSTRACT Aims Diabetes mellitus (DM) is a common comorbidity of psoriatic arthritis (PsA); however, its global prevalence and the impact of treatment exposure remain unclear. This study aimed to assess the global prevalence of DM in patients with PsA using different subgroup analyses.
Jiao Wang, Xuan Zhou, Jiale Chen, Qingyun Wang, Xiaofei Yi, Pengbo Gao, Jingjie He, Shufen Yang, Miao Zhang, Xiaoying Sun, Liu Liu, Xin Li   +11 more
wiley   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source